Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,080 | 859 | 99.9% |
| Education | $17.73 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,802 | 80 | $0 (2024) |
| Novo Nordisk Inc | $1,287 | 124 | $0 (2024) |
| ABBVIE INC. | $1,054 | 72 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $953.41 | 47 | $0 (2024) |
| Lilly USA, LLC | $866.13 | 53 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $849.31 | 54 | $0 (2023) |
| Amgen Inc. | $799.83 | 47 | $0 (2023) |
| PFIZER INC. | $795.99 | 79 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $696.34 | 47 | $0 (2023) |
| GlaxoSmithKline, LLC. | $533.51 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240.95 | 12 | Sumitomo Pharma America, Inc. ($55.14) |
| 2023 | $1,905 | 124 | AstraZeneca Pharmaceuticals LP ($325.90) |
| 2022 | $1,494 | 79 | AstraZeneca Pharmaceuticals LP ($280.02) |
| 2021 | $2,127 | 144 | AbbVie Inc. ($319.90) |
| 2020 | $1,624 | 112 | AstraZeneca Pharmaceuticals LP ($244.71) |
| 2019 | $1,855 | 138 | Lilly USA, LLC ($222.63) |
| 2018 | $1,619 | 121 | SANOFI-AVENTIS U.S. LLC ($234.83) |
| 2017 | $2,233 | 133 | SANOFI-AVENTIS U.S. LLC ($392.45) |
All Payment Transactions
863 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2024 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Respiratory | ||||||
| 01/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Respiratory | ||||||
| 01/22/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: VACCINES | ||||||
| 01/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Oncology | ||||||
| 01/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: UROLOGY | ||||||
| 01/11/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Diabetes | ||||||
| 01/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: UROLOGY | ||||||
| 12/19/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/19/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/07/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.54 | General |
| Category: Cardiovascular | ||||||
| 12/05/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/27/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: Oncology | ||||||
| 11/21/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Cardio-renal | ||||||
| 11/15/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Respiratory | ||||||
| 11/15/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: VACCINES | ||||||
| 11/14/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 827 | 1,223 | $184,399 | $67,267 |
| 2022 | 14 | 878 | 1,198 | $196,257 | $73,333 |
| 2021 | 14 | 821 | 1,230 | $177,286 | $70,499 |
| 2020 | 13 | 858 | 1,188 | $171,823 | $58,243 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 212 | 362 | $85,070 | $27,802 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 183 | 263 | $46,025 | $14,113 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 85 | 85 | $12,750 | $10,917 | 85.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 49 | $16,170 | $5,360 | 33.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $3,000 | $2,458 | 81.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 19 | $1,520 | $1,367 | 89.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 58 | 120 | $6,000 | $1,052 | 17.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 24 | $1,920 | $978.65 | 51.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $3,740 | $789.51 | 21.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 19 | 19 | $2,888 | $690.42 | 23.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 14 | $1,530 | $684.83 | 44.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $756.00 | $644.07 | 85.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 94 | 107 | $2,140 | $231.60 | 10.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $308.00 | $103.41 | 33.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 97 | $582.00 | $76.07 | 13.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 359 | $83,500 | $27,696 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 221 | 305 | $50,900 | $14,937 | 29.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 95 | 95 | $14,250 | $12,423 | 87.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 53 | 64 | $19,920 | $7,521 | 37.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 13 | 13 | $2,600 | $2,171 | 83.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 28 | 28 | $2,240 | $1,851 | 82.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $2,310 | $1,845 | 79.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $5,060 | $1,278 | 25.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 59 | 123 | $6,150 | $1,075 | 17.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 28 | $1,008 | $828.80 | 82.2% |
About Dr. Philip Henry, DO
Dr. Philip Henry, DO is a Family Medicine healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023097946.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Henry, DO has received a total of $13,097 in payments from pharmaceutical and medical device companies, with $240.95 received in 2024. These payments were reported across 863 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($13,080).
As a Medicare-enrolled provider, Henry has provided services to 3,384 Medicare beneficiaries, totaling 4,839 services with total Medicare billing of $269,342. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Spokane, WA
- Active Since 01/10/2006
- Last Updated 11/25/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023097946
Products in Payments
- FARXIGA (Drug) $762.32
- Ozempic (Drug) $738.23
- XARELTO (Drug) $632.33
- BREZTRI (Drug) $555.52
- EVENITY (Biological) $454.43
- SOLIQUA (Drug) $391.69
- VRAYLAR (Drug) $383.31
- SYMBICORT (Drug) $304.69
- INVOKANA (Drug) $303.23
- EMGALITY (Drug) $278.56
- TRULICITY (Drug) $251.16
- ELIQUIS (Drug) $249.95
- TOUJEO (Drug) $247.19
- XIFAXAN (Drug) $246.33
- NURTEC ODT (Drug) $236.83
- Victoza (Drug) $226.80
- TRELEGY ELLIPTA (Drug) $222.22
- QULIPTA (Drug) $220.30
- UBRELVY (Drug) $215.40
- Aimovig (Biological) $187.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Spokane
Duncan Lahtinen, Do, DO
Family Medicine — Payments: $25,033
Dr. Jeffrey Emery, Do, DO
Family Medicine — Payments: $19,386
Gretchen Lasalle, Md, MD
Family Medicine — Payments: $19,308
Mr. Jeffery Trail, Md, MD
Family Medicine — Payments: $13,973
Michael Ravelo, M.d, M.D
Family Medicine — Payments: $7,870
Mark Lahtinen, Do, DO
Family Medicine — Payments: $7,505